AdaptHealth Corp.
Income Statement
| Line Item | Aug 2025 | Jun 2025 | May 2025 | Mar 2025 | Feb 2025 | Dec 2024 | Nov 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $657.1M | — | $777.9M | — | — | — | $805.9M |
| Cost of Revenue | — | $521.3M | — | $657.4M | — | — | — | $643.8M |
| Gross Profit | — | $135.8M | — | $120.4M | — | — | — | $162.1M |
| Gross Margin | — | 20.7% | — | 15.5% | — | — | — | 20.1% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | — | $95.3M | — | $86.9M | — | — | — | $87.3M |
| Operating Income | — | $65.7M | — | $23.2M | — | — | — | $63.5M |
| Operating Margin | — | 10.0% | — | 3.0% | — | — | — | 7.9% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | $38.2M | — | $-5.2M | — | — | — | $32.0M |
| Income Tax Expense | — | $32.8M | — | $850.0K | — | — | — | $8.1M |
| Net Income | — | $14.7M | — | $-7.2M | — | — | — | $22.9M |
| Net Margin | — | 2.2% | — | -0.9% | — | — | — | 2.8% |
| EPS (Basic) | — | $0.10 | — | $-0.05 | — | — | — | $0.16 |
| EPS (Diluted) | — | $0.10 | — | $-0.05 | — | — | — | $0.15 |
| Shares Outstanding (Basic) | 135.3M | 135.0M | 134.9M | 134.8M | 134.9M | 134.6M | 134.6M | 134.3M |
| Shares Outstanding (Diluted) | 135.3M | 137.1M | 134.9M | 134.8M | 134.9M | 134.6M | 134.6M | 136.5M |
| Dividends Per Share | — | — | — | — | — | — | — | — |